These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 37545930)

  • 1. Ginger supplementation for the treatment of non-alcoholic fatty liver disease: a meta-analysis of randomized controlled trials.
    Zhou Q; Peng Y; Chen F; Dai J
    Afr Health Sci; 2023 Mar; 23(1):614-621. PubMed ID: 37545930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic outcome of dapagliflozin in patients with type 2 diabetes and non-alcoholic fatty liver disease: a meta-analysis of randomized controlled trials.
    Hu C; Qu T; Li L; Huang Y; Liu H; Rao C
    Afr Health Sci; 2023 Jun; 23(2):416-421. PubMed ID: 38223613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of carnitine supplementation on clinical characteristics of patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials.
    Abolfathi M; Mohd-Yusof BN; Hanipah ZN; Mohd Redzwan S; Yusof LM; Khosroshahi MZ
    Complement Ther Med; 2020 Jan; 48():102273. PubMed ID: 31987257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Garlic supplementation for the treatment of chronic liver disease: a meta-analysis of randomized controlled trials.
    Xiaohui L; Jinqi L; Xiaofang X; Zhiqiang S; Renxiu N
    Afr Health Sci; 2023 Jun; 23(2):409-415. PubMed ID: 38223588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soy diet for nonalcoholic fatty liver disease: A meta-analysis of randomized controlled trials.
    Xiong P; Zhu YF
    Medicine (Baltimore); 2021 Jun; 100(22):e25817. PubMed ID: 34087824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of vitamin D supplementation on metabolic profiles and liver function in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials.
    Tabrizi R; Moosazadeh M; Lankarani KB; Akbari M; Heydari ST; Kolahdooz F; Samimi M; Asemi Z
    Diabetes Metab Syndr; 2017 Dec; 11 Suppl 2():S975-S982. PubMed ID: 28751149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of ginger intake on weight loss and metabolic profiles among overweight and obese subjects: A systematic review and meta-analysis of randomized controlled trials.
    Maharlouei N; Tabrizi R; Lankarani KB; Rezaianzadeh A; Akbari M; Kolahdooz F; Rahimi M; Keneshlou F; Asemi Z
    Crit Rev Food Sci Nutr; 2019; 59(11):1753-1766. PubMed ID: 29393665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of dietary polyphenol supplementation in the treatment of non-alcoholic fatty liver disease: A systematic review and meta-analysis.
    Yang K; Chen J; Zhang T; Yuan X; Ge A; Wang S; Xu H; Zeng L; Ge J
    Front Immunol; 2022; 13():949746. PubMed ID: 36159792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin D and non-alcoholic fatty liver disease: a meta-analysis of randomized controlled trials.
    Guo XF; Wang C; Yang T; Li S; Li KL; Li D
    Food Funct; 2020 Sep; 11(9):7389-7399. PubMed ID: 32966467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Empagliflozin for the treatment of non-alcoholic fatty liver disease: a meta-analysis of randomized controlled trials.
    Tang X; Zhang H; Wang X; Yang D
    Afr Health Sci; 2022 Sep; 22(3):391-398. PubMed ID: 36910362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A systematic review and meta-analysis of preclinical and clinical studies on the efficacy of ginger for the treatment of fatty liver disease.
    Samadi M; Moradinazar M; Khosravy T; Soleimani D; Jahangiri P; Kamari N
    Phytother Res; 2022 Mar; 36(3):1182-1193. PubMed ID: 35106852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Relationship between Prebiotic Supplementation and Anthropometric and Biochemical Parameters in Patients with NAFLD-A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Stachowska E; Portincasa P; Jamioł-Milc D; Maciejewska-Markiewicz D; Skonieczna-Żydecka K
    Nutrients; 2020 Nov; 12(11):. PubMed ID: 33187278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy of glucagon-like peptide 1 receptor agonists in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis of randomized controlled trials.
    Fan S; Shi X; Yao J; Zhong M; Feng P
    Rev Esp Enferm Dig; 2020 Aug; 112(8):627-635. PubMed ID: 32496108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of curcumin supplementation on liver function, metabolic profile and body composition in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials.
    Jalali M; Mahmoodi M; Mosallanezhad Z; Jalali R; Imanieh MH; Moosavian SP
    Complement Ther Med; 2020 Jan; 48():102283. PubMed ID: 31987259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of ginger (Zingiber officinale) on inflammatory markers: A systematic review and meta-analysis of randomized controlled trials.
    Morvaridzadeh M; Fazelian S; Agah S; Khazdouz M; Rahimlou M; Agh F; Potter E; Heshmati S; Heshmati J
    Cytokine; 2020 Nov; 135():155224. PubMed ID: 32763761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Effects of Ginger (
    Ghoreishi PS; Shams M; Nimrouzi M; Zarshenas MM; Lankarani KB; Fallahzadeh Abarghooei E; Talebzadeh M; Hashempur MH
    J Diet Suppl; 2024; 21(3):294-312. PubMed ID: 37817641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical efficacy and safety of berberine in the treatment of non-alcoholic fatty liver disease: a meta-analysis and systematic review.
    Nie Q; Li M; Huang C; Yuan Y; Liang Q; Ma X; Qiu T; Li J
    J Transl Med; 2024 Mar; 22(1):225. PubMed ID: 38429794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does turmeric/curcumin supplementation improve serum alanine aminotransferase and aspartate aminotransferase levels in patients with nonalcoholic fatty liver disease? A systematic review and meta-analysis of randomized controlled trials.
    Goodarzi R; Sabzian K; Shishehbor F; Mansoori A
    Phytother Res; 2019 Mar; 33(3):561-570. PubMed ID: 30653773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of metformin administration on liver enzymes and body composition in non-diabetic patients with non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitis: An up-to date systematic review and meta-analysis of randomized controlled trials.
    Jalali M; Rahimlou M; Mahmoodi M; Moosavian SP; Symonds ME; Jalali R; Zare M; Imanieh MH; Stasi C
    Pharmacol Res; 2020 Sep; 159():104799. PubMed ID: 32278041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of Omega-3 Polyunsaturated Fatty Acids in Non-Alcoholic Fatty Liver Disease: A Meta-Analysis of Randomized Controlled Trials.
    He XX; Wu XL; Chen RP; Chen C; Liu XG; Wu BJ; Huang ZM
    PLoS One; 2016; 11(10):e0162368. PubMed ID: 27711128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.